- The agreement strengthens the existing relationship with a leading supply partner of Brenntag Specialties’ Life Science businesses
- Customers in the EMEA region can continue to rely on Brenntag Specialties as a supplier of Titaniumdioxide pigments (TiO2) for Pharma and Beauty & Personal Care applications
Brenntag (ISIN DE000A1DAHHO), the global market leader in chemicals and ingredients distribution, today announced an extension of the existing exclusive distribution agreement with KRONOS for Titanium dioxide pigments (TiO2) in the EMEA region. Purified titanium dioxide from KRONOS are effective colorants used in a wide range of applications. The distribution agreement includes KRONOS products for Brenntag Specialties’ customers in Life Science segments, which include pharmaceutical as well as cosmetics and personal care applications.
In scope are the Titanium Dioxide grades KRONOS 1171, KRONOS 2071 and KRONOS 2171, which comply with the product safety legislation 1223/2009/EC (cosmetics), various Pharmacopoeias (Ph. Eur., USP, BP and JP), COSMOS and FSSC 22000. Brenntag Specialties holds a strong foothold in the EMEA-wide Life Science industry and provides a platform to distribute the KRONOS product range to customers.
“In the spirit of continued cooperation and shared success, this renewal marks a pivotal moment in our long-standing collaboration, further solidifying the strategic partnership between Brenntag and KRONOS. We look forward to another period of collaboration and growth,” said Michael Wilkop, Regional President of Brenntag Specialties Beauty & Care / HI&I EMEA.
“The partnership with KRONOS perfectly complements our broad and reliable portfolio of excipients trusted by our customers. In this way, we not only meet global standards in quality and functionality, but also ensure security of supply and first-class expertise for our customers in the pharmaceutical industry,” added Joakim Rehné, Regional President of Brenntag Specialties Pharma EMEA.
“We are enthusiastic about strengthening our partnership with Brenntag Specialties in EMEA! Our extended exclusive distribution agreement reflects a strong bond, delivering cutting-edge solutions for Pharma and Beauty & Personal Care customers. Together, we're shaping a brighter future in Life Science segments,” said Jochen Kürn, Director Global Customer Performance at KRONOS.
KRONOS, one of the world’s leading producers of high-quality titanium dioxide pigments, owes its market position to the quality of its products and its long-standing technical experience. KRONOS’ production capacity is at approximately 550,000 metric tons per year. KRONOS benefits specifically from its long-term know-how and competence based on these decades of experience. KRONOS has six manufacturing sites, which are located in five countries on two continents: in Europe in Leverkusen and Nordenham/Germany, in Fredrikstad/Norway and in Ghent/Belgium; in North America in Lake Charles, Louisiana/USA, and in Varennes, Quebec/Canada.
Brenntag is the global market leader in chemicals and ingredients distribution. The company holds a central role in connecting customers and suppliers of the chemical industry. Headquartered in Essen, Germany, Brenntag has more than 17,500 employees worldwide and operates a network of about 600 sites in 72 countries. In 2022, Brenntag generated sales of around 19.4 billion EUR. The two global divisions, Brenntag Essentials and Brenntag Specialties, provide a full-line portfolio of industrial and specialty chemicals and ingredients as well as tailor-made application, marketing and supply chain solutions, technical and formulation support, comprehensive regulatory know-how, and digital solutions for a wide range of industries. In the field of sustainability, Brenntag pursues specific goals and is committed to sustainable solutions in its own sector and the industries served. Brenntag shares have been listed at the Frankfurt Stock Exchange since 2010, in the DAX since September 2021. In addition, the Brenntag SE shares are listed in the DAX 50 ESG and DAX ESG Target. For more information, visit www.brenntag.com